SBFM News and Press, Sunshine Biopharma Inc. From 02/28/23

Cancer-focused biotech Sunshine Biopharma ( NASDAQ: SBFM ) added ~7% pre-market Tuesday after announcing an exclusive license agreement for worldwide rights related to a COVID-19 targeting drug technology. Sunshine Biopharma ( SBFM ) has inked the deal with the University of A...

Palm Beach, FL – February 28, 2023 – FinancialNewsMedia.com News Commentary –  The Coronavirus Global Market has been growing in the past few years and is anticipated to continue to grow in the next several years. In fact, the whole vaccines market is project...

Montreal – February 28, 2023 – Sunshine Biopharma Inc. (NASDAQ: SBFM), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced the signing of an exclusive worldwide license agreem...

MONTREAL, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced the signing of an exclusive worldwide lic...

Oncology-focused biotech Sunshine Biopharma ( NASDAQ: SBFM ) added ~7% pre-market Friday after announcing a research agreement with the Jewish General Hospital to develop its anticancer agent Adva-27a through IND-enabling studies. Subject to the outcome of initial studies, Sunshin...

MONTREAL, Feb. 10, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced the signing of a research agreement with ...

Sunshine Biopharma ( NASDAQ: SBFM ) has authorized a share repurchase program to acquire up to $2M of the company’s common stock. As of September 30, 2022, the company had approximately $40.5M of cash and cash equivalents. The company had ~22.6M shares of common stock i...

MONTREAL, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced its board of directors has authorized a s...

--News Direct-- To learn more about Sunshine Biopharma, download the latest research report here Sunshine Biopharma Inc. (NASDAQ: SBFM) is a fully integrated pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, inclu...

MONTREAL, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today issued a letter to shareholders from Dr. Steve Slil...